Last Updated : February 24, 2006
Details
FilesGeneric Name:
Treprostinil sodium
Project Status:
Complete
Therapeutic Area:
Pulmonary arterial hypertension (NYHA Class III and IV patients)
Manufacturer:
Northern Therapeutics Inc.
Brand Name:
Remodulin
Project Line:
Reimbursement Review
Project Number:
SR0052-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Resubmission
Indications:
Pulmonary arterial hypertension (NYHA Class III and IV patients)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : February 24, 2006